So a question, and I'm not trying to be a smart a**, why did the SP go from under $2 to over $4 in less then a month?
The only announcement during that time was about a COVID-19.
Was the price severely undervalued prior to that or did the new publicity open the doors to show others all the other good stuff MSB is doing?
Genuinely curious
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-223
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |